Vanderbilt University Licenses Ariadne Pathway Studio
News Jul 12, 2007
Ariadne has announced that Vanderbilt University purchased an unlimited Pathway Studio license for the Department of Cancer Biology. Pathway Studio was chosen for its flexibility in exploring protein-protein interactions and ease of frequent database updates with MedScan® module.
“We evaluated various pathway analysis packages and were impressed by Pathway Studio’s graphics and ease of use.” said Dr. Lynn Matrisian, Chair of the Department of Cancer Biology at Vanderbilt University.
“Most impressive is the MedScan Technology that allows our researchers to extract relationships from the latest publications and add them to the large body of knowledge in the packaged database. The ability to instantly update the database with selected information is of paramount importance in cancer research," Dr. Matrisian continued.
‘We start seeing more and more research groups choosing Pathway Studio over other pathway software based on the availability of MedScan and therefore the researcher’s ability to fully control the database and update it as often as needed”, said Ilya Mazo, President of Ariadne.
“Ease of making custom databases together with the biggest available database of functional relationships and flexibility of pathway analysis queries proves to be the most important advantages of our software among researchers in academia and pharmaceutical companies.”
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE